Multi‐disciplinary team approach for pediatric hemimegalencephaly: Insights from a single institutional case series
Epilepsia Open · 2024-12 · 9 (6) · 2510-2517
DOI: 10.1002/epi4.13079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia Open, online erschienen am 23.10.2024. Verfasst von Benjamin Edmonds und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Hemimegalencephaly, Patient Care Team. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Recent genetic studies have revealed that hemimegalencephaly (HME) is a multi‐system disorder associated with germline or mosaic variants within the PI3K‐mTOR‐GATOR1 signaling pathways. Patients with HME typically develop drug‐resistant epilepsy necessitating extensive evaluation, hemispherectomy, and long‐term management. We describe the role of a multidisciplinary team (MDT) for the diagnosis and management of recent patients with HME at UCLA who underwent hemispherectomy. Genetic evaluation identified nine patients with the following variants: NPRL3 x2 germline, PIK3CA mosaicism x4, MTOR mosaicism x1, AKT3 mosaicism x1, unknown x1. Each patient's MDT comprised 4–9 specialties. One child with a MTOR variant had persistent epilepsy after hemispherectomy, but addition of everolimus resulted in an 80% decrease in seizure frequency. Another child with hemihypertrophy and PIK3CA mosaic variant was offered targeted PIK3CA inhibitor treatment, alpelisib, for overgrowth. A third child with germline NPRL3 variant inherited from their unaffected mother resulted in a sibling being diagnosed with the variant who later developed seizures secondary to focal cortical dysplasia. The implementation of a MDT offers essential guidance for families affected by HME, encompassing prognostication, surveillance, and therapeutic strategies. Identifying the etiology of HME can facilitate the development of targeted treatments and enable timely genetic counseling. Plain Language Summary Hemimegalencephaly (HME) is a complex brain disorder caused by genetic changes. It often leads to severe epilepsy that doesn't respond to standard treatments and frequently requires surgery. In this case series, nine patients with HME were identified and found to have genetic mutations in key growth‐regulating genes. A multidisciplinary team model was developed to facilitate patients' care. For example, one patient's seizures improved with surgery, another with a new targeted medication, and another received treatment for symptoms of overgrowth. This team approach provides comprehensive care for patients and can lead to efficient care coordination and implementation of novel therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, Washington, USA.
- Division of Pediatric Neurology, Department of Pediatrics, David Geffen School of Medicine, UCLA Mattel Children's Hospital, Los Angeles, California, USA.
- Division of Developmental Pediatrics, Department of Pediatrics, David Geffen School of Medicine, UCLA Mattel Children's Hospital, Los Angeles, California, USA.
- Division of Pediatric Endocrinology, Department of Pediatrics, David Geffen School of Medicine, UCLA Mattel Children's Hospital, Los Angeles, California, USA.
- Division of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA Medical Center, Los Angeles, California, USA.
- Department of Ophthalmology, David Geffen School of Medicine, UCLA Medical Center, Los Angeles, California, USA.
ORCID-Profile: Benjamin Edmonds, Shino Magaki, Shaun A Hussain, Aria Fallah, Hiroki Nariai
Förderung
- NINDS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Edmonds, B., Ngo, J. P., Groves, A., Reyes, B., Gott, R. A., Chia, D. J., Mirbaha, H., Magaki, S., Khanlou, N., Pineles, S. L., Salamon, N., Thompson, R. M., Newman, M., Rajaraman, R. R., Hussain, S. A., Fallah, A., Russell, B., & Nariai, H. (2024). Multi‐disciplinary team approach for pediatric hemimegalencephaly: Insights from a single institutional case series. Epilepsia Open, 9(6), 2510-2517. https://doi.org/10.1002/epi4.13079
Vancouver
Edmonds B, Ngo JP, Groves A, Reyes B, Gott RA, Chia DJ, et al. Multi‐disciplinary team approach for pediatric hemimegalencephaly: Insights from a single institutional case series. Epilepsia Open. 2024;9(6):2510-2517. doi:10.1002/epi4.13079
BibTeX
@article{Edmonds2024,
author = {Edmonds, Benjamin and Ngo, Jacqueline P and Groves, Aran and Reyes, Beck and Gott, Rolanda A and Chia, Dennis J and Mirbaha, Hilda and Magaki, Shino and Khanlou, Negar and Pineles, Stacy L and Salamon, Noriko and Thompson, Rachel M and Newman, Maya and Rajaraman, Rajsekar R and Hussain, Shaun A and Fallah, Aria and Russell, Bianca and Nariai, Hiroki},
title = {Multi‐disciplinary team approach for pediatric hemimegalencephaly: Insights from a single institutional case series},
journal = {Epilepsia Open},
year = {2024},
volume = {9},
number = {6},
pages = {2510--2517},
doi = {10.1002/epi4.13079}
}
EUVIMED